LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · IEX Real-Time Price · USD
0.506
+0.006 (1.20%)
Jul 22, 2024, 10:25 AM EDT - Market open
LakeShore Biopharma Employees
LakeShore Biopharma had 773 employees as of March 31, 2023. The number of employees decreased by 92 or -10.64% compared to the previous year.
Employees
773
Change (1Y)
-92
Growth (1Y)
-10.64%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
92.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 773 | -92 | -10.64% |
| Mar 31, 2022 | 865 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 111, Inc. | 1,520 |
| Asensus Surgical | 209 |
| Aclaris Therapeutics | 91 |
| Assembly Biosciences | 65 |
| InflaRx | 62 |
| Eton Pharmaceuticals | 30 |
| Eupraxia Pharmaceuticals | 29 |
| Cellectar Biosciences | 20 |
LSB News
- 17 days ago - LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition - PRNewsWire
- 2 months ago - YS Biopharma Announces Name Change to LakeShore Biopharma - PRNewsWire
- 2 months ago - YS Biopharma Announces Results of Extraordinary General Meeting - PRNewsWire
- 2 months ago - YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer - PRNewsWire
- 3 months ago - YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 3 months ago - YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 - PRNewsWire
- 3 months ago - YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine - PRNewsWire
- 3 months ago - YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 - PRNewsWire